News
-
-
PRESS RELEASE
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
Pentixapharm Holding AG completes rights offering and private placement, raising EUR 20.4 million for PANDA Phase 3 trial, US market expansion, and CXCR4-based theranostic platform development -
-
-
-
-
-
-
-
PRESS RELEASE
Lenzing Group advances strategic transformation
Lenzing Group announces strategic transformation with focus on 'Grow Nonwovens, Reset Textiles' to strengthen financial structure and improve profitability. Measures include cost savings, production footprint optimization, and refinancing plan